Russell Investments »

Eliem Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $540 79 6.85
2024-09-30 $351 69 5.09

More positions owned by Russell Investments

Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Meta Platforms Common Stock (META)
Broadcom Common Stock (AVGO)
Taiwan Semiconductor Manufacturing Company Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Tesla Common Stock (TSLA)
Eli Lilly And Company Common Stock (LLY)
Johnson Johnson Common Stock (JNJ)
J P Morgan Chase And Common Stock (JPM)
Visa Common Stock (V)

View all positions for Russell Investments

Top funds holding Eliem Therapeutics

RA Capital Management
MPM Oncology Impact Management
Braidwell
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors
Millennium Management
Vanguard Capital Management
Kynam Capital Management
Driehaus Capital Management
ADAR1 Capital Management
Susquehanna International
Nan Fung Trinity
Sphera Funds Management
BlackRock

View all funds holding Eliem Therapeutics